Already a number of therapeutic drugs have been developed to target LDH-A in order to interfere with tumour growth and invasiveness [38, 39] while more recent research also suggests that LDH-B would be a viable target to attenuate cancer progression [40]. Here, LDHB is linked to neoplasm.